DR SALLY ANN FORSYTH OBE
Chief Executive Officer, Stevenage Bioscience Catalyst
During her time as CEO at Stevenage Bioscience Catalyst, total private equity investment in biotechnology raised in Stevenage has grown to become comparable with that of Cambridge, London and Oxford.
Sally Ann has been responsible for the strategy, growth and development of four internationally recognised science parks including Stevenage Bioscience Catalyst, Harwell Oxford, Colworth Science Park and Norwich Research Park.
She began her career with Unilever as part of the management training scheme and later had lead responsibility for In-Licensing, Strategic Alliances and Open Innovation within the Unilever Foods and Discovery divisions. Being part of the founding team of Unilever Ventures and Unilever Technology Ventures gave Sally Ann an insight into the needs of growing companies. She gained her property experience through Goodman International where she was Director of Science Parks responsible for the development and management of their UK portfolio.
Sally Ann is passionate about the translation of UK science into world leading innovations and the creation of supportive environments to help early-stage companies grow. She has a PhD in molecular biology from the University of Cambridge and is a qualified management accountant (CGMA).